Authors
Loading...
Systematic review and meta-analysis reveals elevated blood GFAP in individuals with Alzheimer's disease and mild cognitive impairment, indicating its diagnostic utility.
Kim et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: